Dimerix fast-tracks kidney drug trial via new cash raise
MELBOURNE: Dimerix will rapidly expand the phase three clinical trial of its flagship kidney drug
MELBOURNE: Dimerix will rapidly expand the phase three clinical trial of its flagship kidney drug